Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Afeyan Noubar
Relationship:   Director, 10% Owner
City:   Lexington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   8,040,025    

Indirect Shares

   111,880,829      
Direct Value   $18,524,035    

Indirect Value

   $82,314,329      
Total Shares   119,920,854      
Total Value   $100,838,364      


Color Kinetics Inc $0 Receptos, Inc. $0 Editas Medicine, Inc. $18,513,076 Seres Therapeutics, Inc. $10,959 Moderna, Inc. $0 Color Kinetics Inc $0 Receptos, Inc. $0 Editas Medicine, Inc. $18,513,076 Seres Therapeutics, Inc. $10,959 Moderna, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    10   
    0    

     Stock price went up :
    3   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -22.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Color Kinetics Inc CLRK Director 2005-10-03 83,062 2005-10-03 12,000    Premium*  
            Agenus Inc AGEN Director 2006-12-14 0 2006-12-14 0    Premium*  
            Helicos Biosciences Corp HLCSQ Director, 10% Owner 2009-09-18 0 2009-09-18 12,192,640    Premium*  
            Receptos, Inc. RCPT 10% Owner 2013-11-18 1,693,551 0    Premium*  
            DNIB Upwind Inc BIND Director, 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Bg Medicine, Inc. BGMD Director, 10% Owner 2015-12-09 0 2015-12-09 1,286,274    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-02-08 3,964,256 2016-02-08 991,060    Premium*  
            Selecta Biosciences Inc SELB 10% Owner 2016-06-27 0 2016-06-27 1,651,862    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2021-02-08 14,907,627    Premium*  
            Transmedics Group, Inc. TMDX 10% Owner 0 2019-10-29 120,595    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 2019-06-18 15,141 2022-07-05 17,617,352    Premium*  
            Moderna, Inc. MRNA 2024-06-26 2,284,015 2024-06-26 4,632,149    Premium*  
            Axcella Health Inc. AXLA 10% Owner 2020-05-18 0 2022-10-13 8,850,296    Premium*  
            Evelo Biosciences Inc EVLO 2020-06-29 0 2023-07-11 4,977,588    Premium*  
            Codiak Biosciences, Inc. CDAK 10% Owner 0 2022-09-15 1,674,869    Premium*  
            Foghorn Therapeutics Inc. FHTX 10% Owner 2020-10-27 0 2020-10-27 1,851,801    Premium*  
            Sigilon Therapeutics, Inc. SGTX 10% Owner 2020-12-08 0 2023-08-11 0    Premium*  
            Sana Biotechnology, Inc. SANA 10% Owner 2021-02-08 0 2023-09-13 581,695    Premium*  
            Rubius Therapeutics, Inc. RUBY Director, 10% Owner 2021-03-19 0 2021-03-19 17,253,519    Premium*  
            Omega Therapeutics, Inc. OMGA Director, 10% Owner 2021-08-03 0 2023-02-27 21,716,886    Premium*  
* Premium Members only  

Records found :    151         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TMDX Transmedics Group, Inc. 10% Owner   –       –       •   2019-10-29 4 D $0.00 $0 I/I (2,840,191) 0 0 -
  151  Records found
  1   2   3   4   5   6   7     
  Page 7 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us